Search results
Livelsberger Financial Advisory Acquires Shares of 4,103 Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 14 hours agoLivelsberger Financial Advisory bought a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to its most recent 13F filing with ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 1 day agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 1 day ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related...
US FDA approves Merck's pneumococcal vaccine for adults
Reuters· 1 day ago, opens new tab said on Monday the U.S. Food and Drug Administration has approved its...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 14 hours agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
Vanguard Group Inc. Sells 210,463 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 20 hours agoVanguard Group Inc. lessened its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 0.0% during the fourth quarter, according to its most recent filing with the Securities ...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 16 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...